Title: Nomogram for predicting early cancer-related death due to recurrence after liver resection
in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) stage B/C: a
multicenter study
Version: 3 Date: 28 Nov 2024
Reviewer:  Panagiotis Tsibouris
Reviewer's report:
Abstract Abbreviations should be explained in their first appearance in the text Methods
Authors should explain in what way a BCLC HCC stage C could become operable without
any chemotherapy/Immunotherapy and is the fate of extrahepatic metastasis in case of a
limited volume intrahepatic HCC Number of patients belongs in the results section How many
patients had any thrombosis of the portal vein Was postoperative chemotherapy/Immunotherapy
allowed? Had all patients compensating cirrhosis? Were any data on liver stiffness available?
Statistics Power of the study should be calculated
Title: Nomogram for predicting early cancer-related death due to recurrence after liver resection
in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) stage B/C: a
multicenter study
Version: 3 Date: 28 Nov 2024
Reviewer:  Panagiotis Tsibouris
Reviewer's report:
Abstract Abbreviations should be explained in their first appearance in the text Methods
Authors should explain in what way a BCLC HCC stage C could become operable without
any chemotherapy/Immunotherapy and is the fate of extrahepatic metastasis in case of a
limited volume intrahepatic HCC Number of patients belongs in the results section How many
patients had any thrombosis of the portal vein Was postoperative chemotherapy/Immunotherapy
allowed? Had all patients compensating cirrhosis? Were any data on liver stiffness available?
Statistics Power of the study should be calculated
Please review this paper.
user
Title: Nomogram for predicting early cancer-related death due to recurrence after liver resection
in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) stage B/C: a
multicenter study
Version: 3 Date: 28 Nov 2024
Reviewer:  Panagiotis Tsibouris
Reviewer's report:
Abstract Abbreviations should be explained in their first appearance in the text Methods
Authors should explain in what way a BCLC HCC stage C could become operable without
any chemotherapy/Immunotherapy and is the fate of extrahepatic metastasis in case of a
limited volume intrahepatic HCC Number of patients belongs in the results section How many
patients had any thrombosis of the portal vein Was postoperative chemotherapy/Immunotherapy
allowed? Had all patients compensating cirrhosis? Were any data on liver stiffness available?
Statistics Power of the study should be calculated
assistant